Accord’s UK Lenalidomide Launch Kicks Off A Year Of Revlimid Competition

UK Generic Launch Comes Ahead Of Expected Rivals Elsewhere In Europe And US

Wave Sea Rock Erosion
BMS is facing significant erosion of its Revlimid franchise this year • Source: yorgil / Alamy Stock Photo
Generics Bulletin Podcast

Stay ahead of every shift in generics and biosimilars.

Generics Bulletin brings you the latest updates that matter for the off-patent industry.

More from Products

More from Generics Bulletin